JR
Julie Rubinstein (President and COO) filed 23 Form 4 reports in the trailing twelve months (0 purchases, 23 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $2.3M of ADPT (174,303 sh across 4 lots, as filed), executed Mar 11. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
23
0 buys · 23 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$21.0M
shares × price, as filed
Last traded
Nov 6
Filed Nov 6
Median ADV $72.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $21.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
23 filings
Sector per market data · by filing · past 12 months
Most traded names
ADPTRecent filings
ADPTSALE
Adaptive Biotechnologies Corporation
View filing →
$717K54,442 sh across 3 lots
Exec Mar 27
Filed Mar 31 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $802K
57,180 sh across 3 lots
Exec Mar 24
Filed Mar 26 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $770K
57,180 sh across 3 lots
Exec Mar 19
Filed Mar 23 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $762K
57,180 sh across 3 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $2.3M
174,303 sh across 4 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.2M
81,342 sh across 3 lots
Exec Mar 6
Filed Mar 10 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.5M
92,823 sh across 4 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $416K
59,505 sh across 2 lots
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET